A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.

导出 OA

翻译打印收藏纠错

第一作者： Bangrong,Cao

第一单位： Department of Basic Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 55 Renmin Ave. Fourth Section, Chengdu, Sichuan, 610041, China.

作者： Bangrong,Cao ^[1] ; Liping,Luo ^[1] ; Lin,Feng ^[2] ; Shiqi,Ma ^[1] ; Tingqing,Chen ^[1] ; Yuan,Ren ^[1] ; Xiao,Zha ^[1] ; Shujun,Cheng ^[2] ; Kaitai,Zhang ^[3] ; Changmin,Chen ^[4]

作者单位： Department of Basic Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 55 Renmin Ave. Fourth Section, Chengdu, Sichuan, 610041, China. ^[1] State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute & Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. ^[2] State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Cancer Institute & Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. zhangkt@cicams.ac.cn. ^[3] Department of Basic Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, 55 Renmin Ave. Fourth Section, Chengdu, Sichuan, 610041, China. changmin_chen@sichuancancer.org. ^[4]

关键词 11-PPI-Mod Adjuvant chemotherapy Biomarkers Colorectal cancer